Results 91 to 100 of about 3,193,785 (231)

Soluble guanylate cyclase as an alternative target for bronchodilator therapy in asthma

Proceedings of the National Academy of Sciences of the United States of America, 2016
Arnab Ghosh, C. Koziol-White, K. Asosingh, Georgina Cheng, Lisa M Ruple, D. Groneberg, A. Friebe, S. Comhair, J. Stasch, R. Panettieri, M. Aronica, S. Erzurum, D. Stuehr   +12 more
semanticscholar   +1 more source

Bronchodilator effects of ipratropium bromide and albuterol sulfate among subjects with tetraplegia

Journal of Spinal Cord Medicine (JSCM), 2018
G. Schilero, Joshua C. Hobson, Kamaldeep Singh, A. Spungen, W. Bauman, Miroslav Radulovic   +5 more
semanticscholar   +1 more source

Health resource utilization for inpatients with COPD treated with nebulized arformoterol or nebulized formoterol

International Journal of COPD, 2017
Vaidyanathan Ganapathy,1 Michael D Stensland2 1Sunovion Pharmaceuticals Inc., Marlborough, MA, 2Agile Outcomes Research, Inc., Rochester, MN, USA Objective: Arformoterol is the (R,R)-enantiomer of formoterol.
Ganapathy V, Stensland MD
doaj  

Duración del efecto broncodilatador de la furosemida inhalada por pacientes asmáticos

Revista Cubana de Medicina, 2002
Se diseñó un estudio para evaluar si después de 4 h de administrada la furosemida inhalada por pacientes asmáticos con algún grado de obstrucción bronquial, persistía el efecto broncodilatador y se comparó con el salbutamol. Se estudiaron 40 pacientes de
Juan Carlos Rodríguez Vázquez, Pedro Pablo Pino Alfonso, Carlos Gassiot Nuño, Alicia Cid Guedes   +3 more
doaj  

The asthma : An advance on treatment and diagnosis. V. A treatment. 3. Bronchodilator agent ( entering on .BETA.2 adrenoceptor agonist).

, 1996
黒沢 元博, 五十嵐 康, 宮地 良樹   +2 more
openalex   +2 more sources

The MABA approach: a new option to improve bronchodilator therapy

European Respiratory Journal, 2013
M. Cazzola, J. López-Campos, L. Puente-Maestu   +2 more
semanticscholar   +1 more source

Allergosis : Advances in diagnosis and treatment.2.Approach to diagnosis and treatment.2.New usage of allergy remedies.(3).Bronchodilator agent ( .BETA.-receptor stimulant, xanthine derivative and anticholinergic agent ).

, 1993

openalex   +2 more sources

Effect of time of day and seasonal variation on bronchodilator responsiveness: the SPIRO-TIMETRY study. [PDF]

Thorax
Knox-Brown B, Kon FC, Sylvester KP, Jha A.   +3 more
europepmc   +1 more source

COPD prevalence and characteristics among sample of working population. [PDF]

Front Public Health
Stoleski S, Minov J, Mijakoski D, Brborović H, Milošević M, Žaja R.   +5 more
europepmc   +1 more source

The diagnostic value of bronchodilator response in differentiating asthma, COPD, and ACO in fixed airflow obstruction: a retrospective study. [PDF]

BMC Pulm Med
Erbay M, Ayçiçek O, Hocek AB, Özdemir KN.   +3 more
europepmc   +1 more source